Cleared Traditional

Blood Pressure Monitor-Model 2005, 2006-2, 2006-2B (K201467) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K201467 · Bioland Technology, Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
111d
Days
Class 2
Risk

K201467 is an FDA 510(k) clearance for the Blood Pressure Monitor-Model 2005, 2006-2, 2006-2B. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Bioland Technology, Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on September 21, 2020 after a review of 111 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Bioland Technology, Ltd. devices

Submission Details

510(k) Number K201467 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2020
Decision Date September 21, 2020
Days to Decision 111 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 125d · This submission: 111d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 281
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K201467.
InBody
K200442 · Inbody Co., Ltd. · Dec 2020
Electronic Blood Pressure Monitor
K200716 · Shenzhen Pango Electronic Co., Ltd. · Dec 2020
V20, V20a, AVSM3 SNF
K200434 · Mediana Co., Ltd. · Oct 2020
Electronic Blood Pressure Monitor
K200939 · Jiangsu Yuyue Medical Equipment& Supply Co., Ltd. · Aug 2020
Arm-Type Fully Automatic Digital Blood Pressure Monitor
K200649 · Joytech Healthcare Co. , Ltd. · Aug 2020
Microlife Upper Arm Automatic Digital Blood Pressure Monitor
K200738 · Microlife Intellectual Property GmbH · Jul 2020